Therapeutic Asset Ratings
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Ramifentanyl
Cardiovascular Disorder
Helse Fonna
P4
BBB
(73)
Ribavirin
Cirrhosis Of Liver
Peking University People's Hospital
P4
BBB
(73)
Ribociclib
Hormone Receptor-Positive Breast Cancer
BeOne Medicines
P4
BBB
(73)
Rituximab
B-Cell Chronic Lymphocytic Leukemia
Zulfa Omer
P4
BBB
(73)
Rituximab
Diffuse Large B-Cell Lymphoma
Beth Israel Deaconess Medical Center
P4
BBB
(73)
Rituximab
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
P4
BBB
(73)
Rivaroxaban
Transient Ischemic Attack
General Hospital of Shenyang Military Region
P4
BBB
(73)
Rivastigmine
Alzheimer Disease
Anhui Provincial Hospital
P4
BBB
(73)
Rivoceranib
Gastric Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.
P4
BBB
(73)
Rosuvastatin
Metabolic Dysfunction-Associated Steatohepatitis
Beni-Suef University
P4
BBB
(73)
Ruxolitinib
Primary Myelofibrosis
OHSU Knight Cancer Institute
P4
BBB
(73)
Sertraline
Depressive Disorder
Tanta University
P4
BBB
(73)
Simvastatin
Portal Hypertension
Kafrelsheikh University
P4
BBB
(73)
Sitagliptin
Diabetes Mellitus
Second Affiliated Hospital of Soochow University
P4
BBB
(73)
Tenecteplase
Stroke Disorder
Assistance Publique - Hôpitaux de Paris
P4
BBB
(73)
Testosterone Undecylate
Type 2 Diabetes Mellitus
Alexandra Kautzky-Willer
P4
BBB
(73)
Thiotepa
Graft Versus Host Disease
Memorial Sloan Kettering Cancer Center
P4
BBB
(73)
Tirzepatide
Obesity Disorder
Royal North Shore Hospital
P4
BBB
(73)
Valproic Acid
Traumatic Brain Injury
Northwestern University
P4
BBB
(73)
Valproic Acid
Epilepsy
Sanofi
P4
BBB
(73)
(+)-Vincristine
Diffuse Large B-Cell Lymphoma
Beth Israel Deaconess Medical Center
P4
BBB
(73)
(+)-Vincristine
Peripheral T-Cell Lymphoma, Not Otherwise Specified
BeBetter Med Inc
P4
BBB
(73)
Zanubrutinib
B-Cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
P4
BBB
(73)
Anti-Pd-L1 Monoclonal Antibody Shr-1316
Small Cell Lung Carcinoma
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
P3
BBB
(73)
Belzutifan
Renal Cell Carcinoma
Vall d'Hebron Institute of Oncology
P3
BBB
(73)
Showing 651 to 675 of 42,327 assets
Previous
Page 27 of 1694
Next